Clinical Trial of Allogeneic Mesenchymal Cells From Umbilical Cord Tissue in Patients With COVID-19
Stopped Lack of funding
Conditions
Interventions
- BIOLOGICAL: Mesenchymal cells
- DRUG: Standard of care
Sponsor
Hospital Infantil Universitario Niño Jesús, Madrid, Spain
Collaborators